Cyclodextrin cellular delivery system for oligonucleotides

Details Cyclodextrin cellular delivery system for oligonucleotides Cyclodextrin cellular delivery system for oligonucleotides

1995-06-07

1997-04-01

Campbell, Bruce R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 58, 536 245, 935 34, 935 52, A61K 4800

Patent

active

056165650

ABSTRACT:
Disclosed is a composition including an oligonucleotide complexed with a cyclodextrin. The oligonucleotide may be noncovalently associated with the cyclodextrin. Alternatively, the oligonucleotide may be covalently complexed with adamantane which is noncovalently associated with the cyclodextrin. Also disclosed are methods of enhancing the cellular uptake and intracellular concentration of oligonucleotides, methods of increasing the solubility of an oligonucleotide in a cell, and methods of treating a cell for viral infection or to prevent viral infection.

REFERENCES:
patent: 5457187 (1995-10-01), Gmeiner et al.
Loke et al. (1989) Proc. Antl. Acad. Sci. (USA) 86:3474.
Yakubov et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:6454.
Anand et al. (1990) Antiviral Chem. Chemother. 1:41-46.
Horiuchi et al. (1990) J. Pharmaceut. Sci. 79:128-132.
Jansen et al. (1990) Lens Eye Tox. Res. 7:459-468.
Misiura et al. (1990) J. Nucleic Acids Res. 18:4345-4353.
Yoshida et al. (1990) Chem. Pharm. Bull. 38:176-179.
Brewster et al. (1991) Pharmaceut. Res. 8:792-795.
Merkus et al. (1991) Pharmaceut. Res. 8:588-592.
Moriya et al. (1991) J. Med. Chem. 34:2301-2304.
Muller et al. (1991) J. Pharmaceut. Sci. 80:599-604.
Pardridge et al. (1991) FEBS Lett. 288:30-32.
Pitha et al. (1991) J. Pharmaceutic Res. 8:1151-1154.
Simpkins et al. (1991) J. Parenteral Sci. Technol. 45:266-269.
Yaksh et al. (1991) Life Sci. 48:623-633.
Arima et al. (1992) J. Pharm. Soc. Japan 112:65-72 (Abstract only).
Bennett et al. (1992) Mol. Pharmacol. 41:1023-1033.
Nakanishi et al. (1992) Chem. Pharm. Bull. 40:1252-1256.
Shao et al. (1992) Pharm. Res. 9:1157-1163.
Weiner et al. (1992) Pathobiol. 60:206-212.
Barry et al. (1993) Biotechniques 15:1016-1018.
Brinker et al. (1993) Angew. Chem. Int. Ed. Engl. 32:1344-1345.
Krieg et al. (1993) Proc. Natl. Acad. Sci. (USA) 90:1048.
Uekama et al. (1993) J. Pharm. Pharmacol. 45:745-747.
Ueno et al. (1993) J. Am. Chem. Soc. 115:2575-12576.
Weisz et al. (1993) Biochem. Pharmacol. 45:1011-1016.
Zelphati et al. (1993) Antisense Res. Dev. 3:323-338.
Zhao et al. (1993) Antisense Res. Dev. 3:53-56.
Gerloczy et al. (1994) J. Pharmaceut. Sci. 83:193-196.
Zamecnick (1994) Proc. Natl. Acad. Sci. (USA) 91:3156.
Irie, Tetsumi et al., (1992), J. Pharmaceut. Sciences, 81(6), 524-528.
Brewster, Marcus E. et al., (1991), Journal of Pharmaceutical Sciences, 80(4), 380-383.
Frijlink, Henderik W., et al, (1991), Pharmaceutical Research, 8(3), 380-384.
Huraux et al., (1989), Rev. Pneumol. Clin. 45, 99-105.
Agrawal et al., (1992), Antisense Res. & Dev., 2, 261-266.
R Weiss (1991) Science News 139: 108-109.
CA Stein et al (1993) Science 261: 1004-1012.
RI Gelb et al (1983) Life Sciences 33: 83-85.
T Loftsson et al (1991) PZ Wissenschaft 136: 5-10.
N Miller et al (1994) Parasitology Today 10: 92-97.
RA Stull et al (1995) Pharmaceutical Research 12: 465-483.
S Wu-pong (1994) Pharmaceutical Technology 118: 102-114.
RW Wagner (1994) Nature 372: 333-335.
JL Hoffman et al (1970) Biochemistry 9: 3542-3550.

Affiliated with

Also associated with

Rating

Cyclodextrin cellular delivery system for oligonucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclodextrin cellular delivery system for oligonucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclodextrin cellular delivery system for oligonucleotides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-538944